AstraZeneca Pharma India Limited (ASTRAZEN.NS)

INR 7868.7

(-0.45%)

Long Term Debt Summary of AstraZeneca Pharma India Limited

  • AstraZeneca Pharma India Limited's latest annual long term debt in 2023 was 27.83 Million INR , down -24.59% from previous year.
  • AstraZeneca Pharma India Limited's latest quarterly long term debt in 2024 Q1 was - INR , down 0.0% from previous quarter.
  • AstraZeneca Pharma India Limited reported annual long term debt of 36.91 Million INR in 2022, down -26.47% from previous year.
  • AstraZeneca Pharma India Limited reported annual long term debt of 50.2 Million INR in 2021, down -41.83% from previous year.
  • AstraZeneca Pharma India Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.
  • AstraZeneca Pharma India Limited reported quarterly long term debt of 27.83 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of AstraZeneca Pharma India Limited (2023 - 2005)

Historical Annual Long Term Debt of AstraZeneca Pharma India Limited (2023 - 2005)

Year Long Term Debt Long Term Debt Growth
2023 27.83 Million INR -24.59%
2022 36.91 Million INR -26.47%
2021 50.2 Million INR -41.83%
2020 86.3 Million INR -7.2%
2019 93 Million INR 0.0%
2018 - INR 0.0%
2017 - INR 0.0%
2016 - INR 0.0%
2015 - INR 0.0%
2014 - INR 0.0%
2013 - INR 0.0%
2012 - INR 0.0%
2011 - INR 0.0%
2010 - INR 0.0%
2009 - INR -100.0%
2008 625 Million INR 0.0%
2007 - INR 0.0%
2006 - INR 0.0%
2005 - INR 0.0%

Peer Long Term Debt Comparison of AstraZeneca Pharma India Limited

Name Long Term Debt Long Term Debt Difference
Alembic Pharmaceuticals Limited 628.8 Million INR 95.573%
Bafna Pharmaceuticals Limited 107.53 Million INR 74.114%
FDC Limited 2.46 Million INR -1028.792%
Gufic Biosciences Limited 1.53 Billion INR 98.192%
Jubilant Pharmova Limited 31.67 Billion INR 99.912%
Nectar Lifesciences Limited 1.4 Billion INR 98.016%
Orchid Pharma Limited 1.2 Billion INR 97.689%
Alkem Laboratories Limited 400 Million INR 93.041%
Bajaj HealthCare Limited 650.34 Million INR 95.72%
Brooks Laboratories Limited 3.56 Million INR -680.813%
Eris Lifesciences Limited 6.54 Billion INR 99.575%
Glenmark Life Sciences Limited 147.61 Million INR 81.142%
Solara Active Pharma Sciences Limited 1.17 Billion INR 97.63%
Innova Captab Limited 2.1 Billion INR 98.678%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 63.165%
Wanbury Limited 820 Million INR 96.605%
Lupin Limited 1.55 Billion INR 98.207%
Aarti Drugs Limited 2.75 Billion INR 98.989%
Aarti Pharmalabs Limited 400 Thousand INR -6859.0%
Albert David Limited 6.01 Million INR -362.699%
Alembic Limited 73.9 Million INR 62.333%
Biofil Chemicals and Pharmaceuticals Limited - INR -Infinity%
Hester Biosciences Limited 1.81 Billion INR 98.469%
Hikal Limited 4.22 Billion INR 99.342%
Ind-Swift Laboratories Limited 111.62 Million INR 75.063%
Ind-Swift Limited 10.09 Billion INR 99.724%
IOL Chemicals and Pharmaceuticals Limited - INR -Infinity%
Kilitch Drugs (India) Limited - INR -Infinity%
Lincoln Pharmaceuticals Limited - INR -Infinity%
Mangalam Drugs & Organics Limited 133.54 Million INR 79.155%
Medico Remedies Limited 8.67 Million INR -220.987%
Morepen Laboratories Limited 33.64 Million INR 17.253%
Procter & Gamble Health Limited 68.8 Million INR 59.541%
RPG Life Sciences Limited -30.3 Million INR 191.868%
Sigachi Industries Limited 265.79 Million INR 89.527%
Sun Pharmaceutical Industries Limited 13.3 Million INR -109.293%
Suven Pharmaceuticals Limited 212.35 Million INR 86.892%
Themis Medicare Limited 267.74 Million INR 89.603%
Unichem Laboratories Limited 382.22 Million INR 92.717%
Vaishali Pharma Limited 35.98 Million INR 22.641%
Venus Remedies Limited 386.8 Million INR 92.804%
Windlas Biotech Limited 20.18 Million INR -37.939%
ZIM Laboratories Limited 356 Million INR 92.181%
Sakar Healthcare Limited 549.55 Million INR 94.935%
Aurobindo Pharma Limited 21.34 Billion INR 99.87%
Divi's Laboratories Limited 20 Million INR -39.18%
Mankind Pharma Limited 325.81 Million INR 91.457%
Sequent Scientific Limited 1.42 Billion INR 98.05%
Laurus Labs Limited 7.98 Billion INR 99.651%
Neuland Laboratories Limited 449.2 Million INR 93.803%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 88.225%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 98.165%
Zydus Lifesciences Limited 251 Million INR 88.91%
Amrutanjan Health Care Limited 13.96 Million INR -99.284%
Wockhardt Limited 8.91 Billion INR 99.688%
Bal Pharma Limited 363.82 Million INR 92.349%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 99.535%
Bliss GVS Pharma Limited 355.92 Million INR 92.179%
Par Drugs and Chemicals Limited - INR -Infinity%
Caplin Point Laboratories Limited 9.2 Million INR -202.565%
Shilpa Medicare Limited 5.6 Billion INR 99.503%
Valiant Laboratories Limited 750.89 Million INR 96.293%
Ajanta Pharma Limited 235.2 Million INR 88.165%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR 13.67%
Granules India Limited 689.71 Million INR 95.964%
Medicamen Biotech Limited 12.55 Million INR -121.712%
Ipca Laboratories Limited 5.8 Billion INR 99.52%
Syncom Formulations (India) Limited -1.21 Million INR 2383.511%
Piramal Enterprises Limited 535.85 Billion INR 99.995%
Torrent Pharmaceuticals Limited 16.04 Billion INR 99.826%
NATCO Pharma Limited 53 Million INR 47.479%
Suven Life Sciences Limited - INR -Infinity%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 98.483%
Strides Pharma Science Limited 6.71 Billion INR 99.585%
Indoco Remedies Limited 3.51 Billion INR 99.209%
Alpa Laboratories Limited - INR -Infinity%
Lasa Supergenerics Limited - INR -Infinity%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 73.887%